Hill Stephen J.
Lyell Immunopharma, Inc. · Chief Operating Officer
Hill Stephen J. is listed in filings as Chief Operating Officer at Lyell Immunopharma, Inc.. This profile follows SEC Form 4 activity through Feb 12, 2026, including sale activity. Recent filings connect the profile to Lyell Immunopharma, Inc. (LYEL). The current snapshot covers public activity from Feb 26, 2025 to Feb 12, 2026. Reported amounts are shown as $28.9K to $2.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $2.5k109 shares | SellFeb 10, 2026 | $23.12 | $12.92 | |
| $1.5k95 shares | SellNov 10, 2025 | $16.12 | $12.92 | |
| $11k1k shares | SellAug 21, 2025 | $10.54 | $12.92 | |
| $97294 shares | SellAug 12, 2025 | $10.34 | $12.92 | |
| $95891 shares | SellAug 11, 2025 | $10.53 | $12.92 |